Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Clinical trial NCT06993610 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06993610
- Sponsor
- Zura Bio Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-16
- Primary completion
- 2026-11-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.